Search

Displaying results 6401 - 6410 of 10000 in total
  1. Drug

    Etamiphylline

    go.drugbank.com/drugs/DB13592
    Experimental

    Categories: Drugs for Obstructive Airway Diseases
  2. Drug

    Vercirnon

    go.drugbank.com/drugs/DB15250
    Investigational

    Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD.

  3. Drug

    Lutetium Lu177 Edotreotide

    go.drugbank.com/drugs/DB17278
    Investigational

    Synonyms: Dotatoc Lu-177, Edotreotide lutetium Lu-177Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Methylselenocysteine

    go.drugbank.com/drugs/DB12697
    Investigational

    Methylselenocysteine has been used in trials studying the prevention of Prostate Carcinoma and No Evidence of Disease.

    Synonyms: SE-METHYL-SELENO-L-CYSTEINECategories: Compounds used in a research, industrial, or household setting
  5. Drug

    Prolgolimab

    go.drugbank.com/drugs/DB16740
    Investigational

    Categories: PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
  6. Drug

    Propyl Gallate

    go.drugbank.com/drugs/DB12450
    Investigational

    Propyl Gallate is under investigation in clinical trial NCT01450098 (A Study of LY2484595 in Healthy Subjects).

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Siroheme

    go.drugbank.com/drugs/DB02832
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  8. Drug

    Ferroheme C

    go.drugbank.com/drugs/DB03317
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  9. Drug

    Gusperimus

    go.drugbank.com/drugs/DB12692
    Investigational

    Gusperimus has been used in trials studying the treatment of Lupus Nephritis, Wegeners Granulomatosis, and Wegener's Granulomatosis.

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    Ulevostinag

    go.drugbank.com/drugs/DB14721
    Investigational

    TANK-binding kinase 1 (TBK1) signaling and activates nuclear factor-kappa B (NF-kB) and interferon regulatory factor 3 (IRF3) in immune cells in the tumor microenvironment; this leads to the production of pro-inflammatory … This results in a CTL-mediated immune response against tumor cells and causes tumor cell lysis. [L4741]